Diabetes Drug Shows Potential in Slowing Prostate Cancer Progression

Diabetes drug Shows Promise as Prostate Cancer Treatment

A recent international study involving researchers at Umeå University in Sweden has discovered that a type 2 diabetes medication may help slow prostate cancer progression. The research found that drugs regulating the PPARγ protein (peroxisome proliferator-activated receptor gamma) played a key role in reducing cancer recurrence among diabetic patients with prostate cancer. “This is a The post Diabetes drug Shows Promise as Prostate Cancer Treatm…

Diabetes drug shows potential in slowing prostate cancer progression

A drug used to treat type 2 diabetes may also be effective in slowing the progression of prostate cancer.

Anti-diabetes medication: new treatment for prostate cancer ? An anti-diabetic drug, receptor agonist activated by peroxisome proliferators (PPary), pioglitazone (Actos),used to treat... The post Anti-diabetes medication: new treatment for prostate cancer ? appeared first on World News.

Anti-Diabetic Drug Could Offer New Treatment for Prostate Cancer

Research reveals pioglitazone, a diabetes drug, may slow prostate cancer progression, offering new hope for patients with both conditions.

Although before the life forecast of patients with cncer de pr stata is measured in months, for advances more dicos today is in os.

Type 2 diabetes may increase risk of advanced cancer

A major international study by the International Agency for Research on Cancer has uncovered a concerning link between type 2 diabetes and the diagnosis of late-stage cancers. The findings suggest that people living with type 2 diabetes are more likely to be diagnosed with advanced cancers, particularly those types that are not typically included in […] The post Type 2 diabetes may increase risk of advanced cancer appeared first on Knowridge Sci…